Heard on the Street: Novo Nordisk and Pfizer are showing some desperation in their gloves-off fight for the obesity-drug assets of Metsera

Dow Jones – HealthSunday, November 2, 2025 at 10:30:00 AM
NegativeHealth
Heard on the Street: Novo Nordisk and Pfizer are showing some desperation in their gloves-off fight for the obesity-drug assets of Metsera
Novo Nordisk and Pfizer are in a fierce and desperate competition for the obesity-drug assets of Metsera, highlighting the intense pressure in the pharmaceutical industry to secure effective treatments for obesity. This battle not only reflects the high stakes involved in the obesity market but also raises concerns about the lengths companies will go to in order to gain an edge, potentially impacting innovation and pricing in the sector.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Pfizer sues to stop rival bid for drugmaker Metsera by Denmark’s Novo Nordisk
NegativeHealth
Pfizer has initiated legal action to block a competing bid from Denmark's Novo Nordisk for the drugmaker Metsera, which is valued at nearly $5 billion. This lawsuit highlights the intense competition in the pharmaceutical industry, where companies are vying for strategic acquisitions to bolster their portfolios. The outcome could significantly impact Pfizer's plans and the overall market dynamics.
Pfizer has filed a lawsuit seeking to block Novo Nordisk from circumventing Pfizer’s deal for weight-loss drug startup Metsera
NegativeHealth
Pfizer has taken legal action against Novo Nordisk, claiming that their attempt to acquire the weight-loss drug startup Metsera violates Pfizer's existing deal. This lawsuit highlights the competitive tensions in the pharmaceutical industry, particularly in the lucrative weight-loss market, and raises questions about the future of Metsera and its potential impact on obesity treatments.
Health Care Roundup: Market Talk
NeutralHealth
In the latest Market Talks, insights on major players in the health care sector, including Eli Lilly, Novo Nordisk, and Pfizer, are discussed. This roundup is important as it provides investors and stakeholders with valuable information on market trends and company performances, helping them make informed decisions in a rapidly evolving industry.
Two developments Thursday–Eli Lilly’s strong quarterly performance and Novo Nordisk’s unsolicited $9 billion bid for a startup–show why drugmakers can’t get enough of weight loss
PositiveHealth
Recent developments in the pharmaceutical industry highlight the growing interest in weight loss solutions. Eli Lilly reported strong quarterly results, while Novo Nordisk made headlines with a $9 billion unsolicited bid for a startup. These moves underscore the immense potential of the $72 billion anti-obesity market, showcasing why drugmakers are eager to invest in this lucrative sector.
Health Care Roundup: Market Talk
NeutralHealth
In the latest Market Talks, insights on major players in the health care sector, including Eli Lilly and Pfizer, are highlighted. This roundup is essential for investors and stakeholders looking to understand market trends and the performance of these pharmaceutical giants.
Latest from Health
FDA restricts use of kids' fluoride supplements, citing emerging health risks
NegativeHealth
The FDA has decided to restrict the use of fluoride supplements for children, highlighting emerging health risks associated with their use. This decision is significant as it reflects growing concerns about the potential negative effects of fluoride on young children's health, prompting parents and caregivers to reconsider the necessity of these supplements in dental care.
They were promised a lifeline to 'graduate' from poverty. Then it was taken away
NegativeHealth
Thousands of South Sudanese refugees and impoverished locals in Uganda were filled with hope thanks to a new USAID-funded project that promised financial support and business coaching. However, their dreams were dashed when funding cuts were announced, leaving many without the lifeline they desperately needed to escape poverty. This situation highlights the fragility of aid programs and the impact of budget constraints on vulnerable communities.
Traitors star is 'grateful for abnormal anatomy'
PositiveHealth
The Traitors star has expressed gratitude for a rare medical condition that ultimately led to a crucial diagnosis after enduring years of pain. This story highlights the importance of medical awareness and how unusual health issues can sometimes provide answers that improve quality of life. It's a reminder that even challenging situations can lead to positive outcomes.
The time change is a chance to reset your sleep schedule – especially for teens
PositiveHealth
This weekend's time change offers a great opportunity for teens to reset their sleep schedules and improve their overall sleep quality. Experts suggest that adjusting to the new time can help teens establish healthier sleep habits, which are crucial for their development and well-being. With practical tips from sleep doctors, parents can support their teens in making this transition smoother, ensuring they get the rest they need to thrive.
Heard on the Street: Novo Nordisk and Pfizer are showing some desperation in their gloves-off fight for the obesity-drug assets of Metsera
NegativeHealth
Novo Nordisk and Pfizer are in a fierce and desperate competition for the obesity-drug assets of Metsera, highlighting the intense pressure in the pharmaceutical industry to secure effective treatments for obesity. This battle not only reflects the high stakes involved in the obesity market but also raises concerns about the lengths companies will go to in order to gain an edge, potentially impacting innovation and pricing in the sector.
What to know about saturated fat as RFK Jr. touts whole milk and beef tallow
NeutralHealth
RFK Jr. is advocating for the inclusion of saturated fats in future U.S. dietary guidelines, specifically promoting whole milk and beef tallow. This stance has sparked discussions about the role of saturated fats in our diets and what current scientific research suggests. As dietary guidelines evolve, understanding the implications of such recommendations is crucial for public health.